Up next is "Healthcare Disparities in Cardiovascular Disease: Social and Nutrition Deserts" by Joshua J. Joseph, MD, MPH, FAHA (@joshuajosephmd), moderated by S. Sethu K. Reddy, MD (@endocrineguru) at #AACECVMET#AACE#Endotwitter
@joshuajosephmd@endocrineguru Diabetes prevalence & hospital admissions correlate w/ residential security maps. The 1930s Home Owners Loan Corporation redlining score has an impact today: 1 unit-higher HOLC grades assoc w/ 54% higher DM mortality & 67% higher rate of diabetes years of life lost #AACECVMET
@joshuajosephmd@endocrineguru Food security is having enough calories. Nutrition security is having the right calories. 20.4% are Food Insecure: 7.8% choose between buying food & paying for medical care/meds, 15.7% choose between buying food or paying rent/mortgage #AACECVMET
@joshuajosephmd@endocrineguru 6 cross-cutting themes of successful disparity interventions: target multiple pt barriers rather than 1 solution, culturally tailor interventions, use multidisciplinary teams, employ interactive skills based pt learning, use pt navigators, involve family/community! #AACECVMET
@joshuajosephmd@endocrineguru Training providers in communication skills results in substantial and significant improvements in patients taking medications. Improved provider communication & shared decision making improved medication adherence among Black adults #AACECVMET
@joshuajosephmd@endocrineguru Life's Simple 7 Health Factors from the AHA shows area to target with meaningful community partnerships that engage individuals/communities, eg. health screenings, health coaches, Community Health Workers #AACECVMET#AACE
@joshuajosephmd@endocrineguru Racial-Ethnic Disparities have been noted in Diabetes Tech use among young adults with T1DM: CGM use was 53% in White patients and 31% in Black patients with type 1 DM; insulin pump use 61% in White patients and 20% in Black patients. #AACECVMET#Endotwitter#T1DM
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Excited for the second session of Day 2 of #AACECVMET where Ralph A. DeFronzo, BMS, MD, MS, BS (@UTHealthSA) talks about "SGLT2 Inhibitors and GLP-1 RAs: Cardio-Renal Metabolic Drugs for the Ages", moderated by Joseph A. Vassalotti, MD (@Joe_Vassalotti) #EndoTwitter#diabetes
@UTHealthSA@Joe_Vassalotti SGLT2 inhibitors: reduce HbA1C, corrects a novel pathophysiologic defect, reversal of glucotoxicity, promotes weight loss, reduces blood pressure, no hypoglycemia, and complements action of other antidiabetic agents = improves glycemic control and CV risk factors #AACECVMET
Day 2 of #AACECVMET starts with "Protecting Our Patients: Implementing Immunization Recommendations Within a Culture of Vaccine Confidence" by Kenneth Izuora, MD, MBA, FACE, moderated by Betul Hatipoglu, MD @TheAACE#AACE#EndoTwitter
@TheAACE During flu seasons, influenza vaccinations reduce all-cause mortality in adult patients with type 2 diabetes by 50% #AACECVMET#MedTwitter#AACE
@EndocrinologyM@utmbhealth Pheochromocytoma Cardiovascular & Metabolic complications include commonly tachycardia & HTN, but also MI, ventricular rupture, catecholamine cardiomyopathy, hemorrhagic stroke, aortic dissection, and hyperglycemia+fatty liver+ weight loss together! #AACECVMET#Endotwitter
@EndocrinologyM@utmbhealth Primary Aldosteronism is excess renin-independent aldosterone & the most common cause of secondary HTN! There are low rates of screening & diagnosis (<1% ever screened). It has higher end-organ damage than primary HTN. It is curable or treatable with targeted therapy. #AACECVMET
Session 2 of #AACECVMET that I'm attending is "Nonalcoholic Fatty Liver Disease: The Global Pandemic" by Dr. Scott Isaacs, MD (@EmoryMedicine)! #WeAreAACE
@EmoryMedicine Pathogenic drivers of NAFLD: genetics, epigenetics, dysbiosis, dysfunctional adipose tissue, insulin resistance, and calorie excess #AACECVMET
@EmoryMedicine All stages of NAFLD show increased mortality over a 30yr period, with mortality increasing with fibrosis stage #AACECVMET#NAFLD
Kicking off Day 1 of @TheAACE Cardiometabolic Conference with "AACE Guideline Update: Developing a Diabetes Mellitus Comprehensive Care Plan" by Lawrence Blonde, MD (Ochsner Medical Center), moderated by S. Sethu K. Reddy, MD (CMU College of Medicine) #WeAreAACE#EndoTwitter
@TheAACE Grade B rec: Artificial intelligence systems, authorized by the FDA for detecting greater than mild diabetic retinopathy, can be used as an alternative to traditional screening approaches...facilitate diagnosis of vision-threatening retinopathy #AACE#Diabetes
Grade A: In T2DM and established ASCVD (or high risk) use GLP-1 RAs with proven CV benefits to reduce the risk of myocardial infarction, stroke, or CV death regardless of other glucose-lowering or cardiovascular therapies and independent of A1C #AACE#AACECVMET